Impact of Aging on the Intestinal Stem Cell Niche and Colorectal Cancer 2025 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION AND THE AMERICAN CANCER SOCIETY Omer Yilmaz, PhD, Massachusetts Institute of Technology; Andrew Chan, MD, MPH, Massachusetts General Hospital Read More
Aging-Associated Inflammation in Lung Cancer Evolution 2025 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION AND THE AMERICAN CANCER SOCIETY Tuomas Tammela, MD, PhD, Memorial Sloan Kettering Cancer Center; Alexander Tsankov, PhD, Icahn School of Medicine at Mount Sinai Read More
Targeting LINE-1 to Prevent Age-Dependent Immune Dysfunction in Cancer 2025 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION, THE CANCER RESEARCH INSTITUTE AND THE AMERICAN CANCER SOCIETY Miriam Merad, MD, PhD and Nicholas Vabret, PhD, Icahn School of Medicine at Mount Sinai; Vera Gorbunova, PhD, University of Rochester Read More
Senescence-Associated Metabolism in Age-Related Tumorigenesis 2025 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION AND THE AMERICAN CANCER SOCIETY Corina Amor Vegas, MD, PhD, Cold Spring Harbor Laboratory; Joshua Rabinowitz, MD, PhD, Princeton University Read More
Reducing Aging-Associated Blood Cancers by Understanding How TNFα Signaling Causes Dormancy and Transformation of Hematopoietic Stem Cell Subsets 2025 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION AND THE AMERICAN CANCER SOCIETY Jennifer Trowbridge, PhD, The Jackson Laboratory; Peter van Galen, PhD, Brigham and Women’s Hospital Read More
Directly Targeting Gq/11 Proteins for Uveal Melanoma Therapy 2026 Drug Discovery Award Aashish Manglik, MD, PhD; Michelle Arkin, PhD; and Boris Bastian, MD, PhD, University of California, San Francisco Read More
A Novel Molecular Glue Degron Motif for Targeted Degradation 2026 Drug Discovery Award Eric Fischer, PhD, and Scott Armstrong, MD, PhD, Dana-Farber Cancer Institute Read More
TRIM21 E3 Ligase Reprogramming for Cancer Therapy 2026 Drug Discovery Award Steven Corsello, MD, and Nathanael Gray, PhD, Stanford University Read More
Biparatopic Antibodies Targeting Receptor Tyrosine Kinases in Cancer 2026 Drug Discovery Award William Sellers, MD; Alex Burgin, PhD, Broad Institute of MIT and Harvard Read More
